OSTX
OS Therapies Incorporated
1.81
5700 x 1.81
2900 x undefined
bid
ask
-
0.09
4.74%
4300 @ 08:37 AM
1.81 +0.00 (0.00%)
| Ytd | 29.29% | |
| 1y | -6.22% |
1.80
day range
1.93
1.15
52 week range
2.57
| Open | 1.91 | Prev Close | 1.90 | Low | 1.80 | High | 1.93 | Mkt Cap | 80.61M |
| Vol | 564.79K | Avg Vol | 785.10K | EPS | -1.07 | P/E | N/A | Forward P/E | 2.57 |
| Beta | N/A | Short Ratio | 1.22 | Inst. Own | 0.75% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-14 | 50-d Avg | 1.77 | 200-d Avg | 1.67 | 1yr Est | 12.67 |
| Income Statement | |||
| Operating Expenses | 10.17M | ||
| Research and Development Expense | 7.35M | ||
| Selling, General and Administrative Expense | 2.82M | ||
| Operating Income | -10.17M | ||
| Interest Expense | 75.34K | ||
| Net Income | -10.40M | ||
| Net Income Common Stock | -10.40M | ||
| Net Income Common Stock (USD) | -10.40M | ||
| Consolidated Income | -10.40M | ||
| Earnings per Basic Share | -0.27 | ||
| Earnings per Basic Share (USD) | -0.27 | ||
| Earnings per Diluted Share | -0.27 | ||
| Earning Before Interest & Taxes (EBIT) | -10.32M | ||
| Earning Before Interest & Taxes (USD) | -10.32M | ||
| Weighted Average Shares | 38.67M | ||
| Weighted Average Shares Diluted | 38.67M | ||
| Balance Sheet | |||
| Cash and Equivalents | 917.55K | ||
| Cash and Equivalents (USD) | 917.55K | ||
| Current Assets | 917.55K | ||
| Property, Plant & Equipment Net | 1.80K | ||
| Total Assets | 7.30M | ||
| Debt Current | 1.34M | ||
| Total Debt | 1.34M | ||
| Current Liabilities | 16.95M | ||
| Total Liabilities | 17.05M | ||
| Accumulated Retained Earnings (Deficit) | -77.58M | ||
| Shareholders Equity | -10.82M | ||
| Shareholders Equity (USD) | -10.82M | ||
| Assets Non-Current | 6.38M | ||
| Total Debt (USD) | 1.34M | ||
| Goodwill and Intangible Assets | 6.38M | ||
| Liabilities Non-Current | 100.00K | ||
| Trade and Non-Trade Payables | 15.61M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 124.94K | ||
| Net Cash Flow from Financing | 5.21M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 647.72K | ||
| Issuance (Purchase) of Equity Shares | 3.38M | ||
| Issuance (Repayment) of Debt Securities | 1.84M | ||
| Net Cash Flow from Operations | -4.56M | ||
| Share Based Compensation | 1.44M | ||